Information Journal Paper
APA:
CopyBROWN, D.M., KAISER, P.K., MICHELS, M., SOUBRANE, G., HEIER, J.S., & KIM, R.Y.. (2006). RANIBIZUMAB VERSUS VERTEPORPHIN FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. NEW ENGLAND JOURNAL OF MEDICINE (NEJM), 355(14), 1432-1444. SID. https://sid.ir/paper/563150/en
Vancouver:
CopyBROWN D.M., KAISER P.K., MICHELS M., SOUBRANE G., HEIER J.S., KIM R.Y.. RANIBIZUMAB VERSUS VERTEPORPHIN FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. NEW ENGLAND JOURNAL OF MEDICINE (NEJM)[Internet]. 2006;355(14):1432-1444. Available from: https://sid.ir/paper/563150/en
IEEE:
CopyD.M. BROWN, P.K. KAISER, M. MICHELS, G. SOUBRANE, J.S. HEIER, and R.Y. KIM, “RANIBIZUMAB VERSUS VERTEPORPHIN FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION,” NEW ENGLAND JOURNAL OF MEDICINE (NEJM), vol. 355, no. 14, pp. 1432–1444, 2006, [Online]. Available: https://sid.ir/paper/563150/en